340 likes | 561 Views
Hepatitis Viruses. Chapter 22. 肝炎病毒. pathogen of viral hepatitis. Introduction. 1. Human hepatitis viruses. HAV (+ssRNA) , HBV (dsDNA) , HCV (+ssRNA) , HDV ( – ssRNA) and HEV (+ssRNA) HGV (+ssRNA) and TTV ( –ssDNA). 2.Other viruses of causing viral hepatitis.
E N D
Hepatitis Viruses Chapter 22 肝炎病毒 pathogen of viral hepatitis
Introduction 1. Human hepatitis viruses HAV(+ssRNA), HBV(dsDNA), HCV(+ssRNA) , HDV(–ssRNA)andHEV(+ssRNA) HGV(+ssRNA) and TTV(–ssDNA) 2.Other viruses of causing viral hepatitis (CMV,EBV,Rubella virus,VZV,Yellow fever virus,etc.)
Hepatitis A virus 甲型肝炎病毒(HAV) *pathogen of hepatitis type A *classified as Hepatornaviridae (肝RNA病毒属)
Ⅰ.Biological Properties 1. Shape and structure capsomere VP1-4 Naked virus •spherical particle(d=27nm) •icosahedral nucleocapsid Genome •ssRNA (positive stranded)•can code for polyprotein,RNA polymerase and proteinase ↓ Cleave 4 polypeptide (VP1 to VP4) ↓ capsomere→capsid
Antigenicity ofcapsid protein:HAV-Ag (only one serotype) 2.Resistance stable to treatment with ether(乙醚), acid (PH3) and heat(60℃ for 1 hour) tolerate boiling for 5 minutes 3.Cultivation infective model(黑猩猩、狨猴、红面猴) cell culture (原代肝细胞或恒河猴胚肾传代细胞) (multiply slowly, non-CPE)
Ⅱ.Pathogenicity and Immunity 1.Pathogenicity Source of infection by fecal-oral route (通过粪-口途径传播 ) Route of transmission Feature of HAV-infection •asymptomatic or only mildly ill •acute hepatitis of short incubation •fulminant hepatitis and favorable prognosis 很常见 罕见慢肝和携带者 罕见暴发性肝炎,预后良好
2.Pathogenesis Virus in feces Intestine and local lymphoid tissue by fecal-oral route (污染食物和水) (replication) blood liver 通过日常生活接触→散发性肝炎 通过污染食物和水→肝炎的暴发流行 Immunopathogenesis Damage caused by HAV ?
---long-lasting immunity 3.Immunity virus in blood IgM anti-HAV+---recent infection antibody to HAV(IgG---lifetime persistence)
Ⅲ.Laboratory Diagnosis 1.Detection of viral antibody IgM anti-HAV (ELISA,早期诊断) IgG anti-HAV (ELISA,既往感染/流调) 2.Detection of virus particles in feces(IEM) 3.Detection of viral RNA Ⅳ.Specific Prevention 1.Artificial active immunity 2.Artificial passive immunity (vaccine---strain H2 ) (gamma globulin)
Hepatitis B Virus 乙型肝炎病毒 Pathogen of hepatitis B
Ⅰ.Biological Properties in the blood of patients with HB 1.Shape and structure Shape ---three viral particle in the blood of infected persons •largerspherical particle •small spherical particle •tubular particle/filaments virion of HBV, i.e. Dane particle 42 nm 1:1730:120
Structure of virion ---Spherical particle with double-shelled capsid ⑴outer shell (contains HBsAg, Pre-S1 and Pre-S2 Ag) ⑵viral core---nucleocapsid HBcAg (d=27nm) HBsAg •surface---inner shell •core DNA polymerase dsDNA (contain HBcAg and HBeAg) core protein kinase *ds-DNA *DNA polymerase *Protein kinase 27nm d=42nm
2.Genome structure Circular ds-DNA(has a single-chain region) –DNA Pre-S2 Pre-S1 •long chain---complete•4 ORF (open reading frames) S P -DNA +DNA +DNA (short chain ---variable length) DR1 DR2 C 5‘ Sticky end & direct repeat (DR1,2) Pre-C X (DNA成环和病毒复制的关键序列)
3.Replication of HBV Unique mode of replication ---retrovirus-like pathway of replication Replicative cycle (p287 Figure 22-5) dsDNA DNA多聚酶 外衣壳蛋白 (HBsAg) 完整的环状ds-DNA 子代HBV 作为mRNA 转译 cccDNA 转录 2.1kbRNA RNAP dsDNA 转译 内衣壳蛋白 (HBcAg) 3.5kbRNA 与负链结合 与DNAP进入内衣壳 前基因组 -DNA +DNA 逆转录 复制
4.Compositions of antigen • Hepatitis B surface antigen(HBsAg) • Hepatitis B core antigen(HBcAg) • Hepatitis B e antigen(HBeAg) • Other antigen (Pre-S1, Pre-S2 antigen, HBxAg)
HBsAg ⑴Exist in blood from infected person with HBV •outer shell of Dane particle • small spherical particle • tubular particle HBsAg
⑵ Subtypes of HBsAg •contains common epitope a , subtype epitope d/y and w/r • 4 major subtypes ---- adr , adw , ayr , ayw ⑶HBsAg+---marker of HBV infection ⑷Anti-HBs:neutralizing antibody •具有免疫保护作用 •抗-HBs+表示感染过/患病已恢复/接种过疫苗获得免疫力
HBcAg (cann’t find in serum) ⑴Locate in surface of viral core ⑵Anti-HBc+---marker of viral infection and replication • IgM anti-HBc+ ---active replication of HBV •IgG anti-HBc+ ---past infection *marker of recent infection *high titers---marker of acute hepatitis B (non-neutralizing Ab)
HBeAg ⑴Exist in HBsAg-positive serum ⑵Associated with presence of Dane particles and DNAP ⑶HBeAg+---marker of virus replication and high infectivity of serum ⑷Anti-HBe+ ----marker of lower infectivity
5.Animal model and cell culture 6.Resistance of HBV •stable to heat(60℃ for 4 hour) •disinfectant (常用0.5%过氧乙酸和5% 次氯酸钠)•高压灭菌法、100 ℃加热10分钟和环氧乙烷可灭活病毒
Ⅱ.Pathogenicity and Immunity Source of infection 1.Pathogenicity •patients with hepatitis B •asymptomatic HBsAg carrier (无症状HBsAg携带者,ASC) Route of transmission •via infected blood or blood products •vertical transmission 杜绝医源性传播!
Feature of HBV-infection •Diversity of clinical finding ---ASC, acute/chronic or fulminant hepatitis •Long incubation hepatitis •Liver damage is caused by the host immunologic response •prognosis *progress toward choronic (10%) *leading to hepatocirrhosis *often associated with primary hepatocellular carcinoma (肝硬化) (原发性肝细胞癌)
Pathogenesis ---liver damage is caused by the host immunologic response ⑴immunopathogenic damage mediated by cellular immunity ⑵pathogenic damage caused by IC ⑶pathogenic damage caused by autoimmunity ⑷immune tolerance & chronic hepatitis ⑸viral variation & immune escape (CTL,CD4+T;CKs→→→急性、慢性、重症肝炎和肝硬化) (重症肝炎以及肝外症状) (LSP→慢迁肝和慢活肝)
2.Immunity ---neutralization of anti-HBs (清除血中的游离病毒) • Specific humoral immunity • Specific cellular immunity 抗-PreS1、抗Pre-S2 也有保护作用 ---double effects mediated by CTL •免疫保护作用---清除细胞内病毒 •免疫损伤作用---参与致病作用 3.HBV & primary hepatocellular carcinoma
Ⅲ.Laboratory Diagnosis • Detection of viral antigens and • antibodys Including : HBsAg, anti-HBs , anti-HBc, HBeAg and anti-Hbe Methods :ELISA or RIA Clinical analysis and signification (“二对半”的检测)
p291 二对半检测结果的临床分析 HBsAg HBeAg anti-HBs anti-HBe anti-HBc 结果分析 + ––––HBV感染者或ASC ++ – – – 急性/慢性肝炎或 ASC (传染性强) ++– –+ 急性/慢性肝炎或 ASC (传染性强) +––++急性感染趋向恢复 ––+++既往感染恢复期 ––++–既往感染恢复期 ––––+ 既往感染/ 窗口期 ––+––对再感染有免疫力 (恢复期、既往感染或接种过疫苗) “大三阳” “小三阳”
“二对半”的检测的实际应用 ⑴特异性诊断 ⑵筛选供血者 ⑶判断病人、ASC和孕妇的传染性 ⑷估计病人的转归和预后 ⑸流行病学调查与追踪传染源 ⑹确定母婴传播阻断对象 “大三阳”, IgM抗-HBc+ ; HBsAg单项阳性(ASC) 筛去HBsAg+,抗-HBc+ HBsAg+伴HBeAg+ •HBsAg+与HBeAg+在2 个月内阴转—好 •“大三阳”持续6个月以上---慢性转化 •慢活肝HBeAg一旦 消失示病情好转 (抗-HBs 和HBsAg及其亚型的检测) 2.Detection of HBV-DNA HBV-DNA+----病毒正在复制,其血清传染性强
Ⅳ.Principle of prevention 1.General prevention 2.Specific prevention Artificial active immunity Artificial passive immunity Passive-active immunity vaccine (HBIg) (HBIg+vaccine)
Hepatitis C virus 丙型肝炎病毒 1.General properties 30-60nm spherical particle, enveloped virus Genome structure ( p297) ---linear ss-RNA (positive strand) 2.Pathogenicity Souse of infection Route of transmission Cause hepatitis C 患者或慢性携带者 血源性传播为主 非经血传播→散发性丙肝 血源性传播→输血后丙肝
Feature of HCV-infection •asymptomatic, acute hepatitis and chronic hepatitis • cause extrahepatic damage • prognosis (40% ~ 50%) 肾小球肾炎 *progress to hepatocirrhosis (20%) *often associated with primary cellular carcinoma 3.Diagnosis 4.Prevention --- detection of HCV-RNA and anti-HCV 抗-HCV+表示已感染HCV (不可献血) Stop iatrogenic transmission!!! 严格筛选供血者,使用灭活的血制品
Hepatitis D virus 丁型肝炎病毒 1.Shape & structure Shape structure RNA HBsAg HDAg •capsid:HBsAg •viral core *genome: circular –ssRNA *HDAg( P24,P27) 35-37 nm HDV--- defective virus (helper virus: HBV)
2.Pathogenicity Hematogenic transmission Cause acute hepatitis D •coinfection (联合感染或共同感染) •superinfection(重叠感染) 3.Diagnosis (detection of anti-HD, HD-Ag and HDV-RNA)
Hepatitis E virus 戊型肝炎病毒 1.Shape & structure Shape •32-34nm spherical particle •naked virus with appearance of a calicine 形似杯状 Genome ---+ssRNA (p301 Figure 29-11)
2.Pathogenicity Route of transmission Cause acute hepatitis E (by fecal-oral route) 水源污染→暴发流行 流行及临床似甲肝 3.Diagnosis (detection of HEV-RNA and anti-HEV)